Some health insurance policies will cover them if certain criteria is met, while some dont cover these medications under any circumstances
The general consensus is that any increased risk of retinopathy with GLP-1 RA treatment is likely to be related to the abrupt improvement in glycemic control [108], a phenomenon similar to that reported for other neuropathological complications [109]
By mimicking the action of the glucagon-like peptide-1 (GLP-1) hormone, these medications slow gastric emptying, increase the feeling of fullness, and reduce calorie intake, resulting in significant weight loss over time
This hormone dictates whether you are in storage mode or burning mode
Spotlight commentary: changes in pharmacokinetics following significant weight loss
By targeting these pathways, Zepbound not only helps control appetite and slow gastric emptying but also improves blood sugar regulation